Some apolipoproteins linked to incident type 2 diabetes

January 5, 2017

(HealthDay)—Apolipoprotein (apo) CIII and apoCIII-to-apoA1 ratio are correlated with incident type 2 diabetes (T2D), according to a study published online Dec. 28 in Diabetes Care.

Adela Brahimaj, M.D., from the Erasmus University Medical Center in Rotterdam, Netherlands, and colleagues used data from 971 individuals from the prospective population-based Rotterdam Study to examine the role of apolipoproteins on the risk for T2D. They examined the correlation of high-density lipoprotein cholesterol (HDL-C), apoA1, apoCIII, apoD, and apoE and the ratios of apolipoproteins with apoA1 with T2D risk.

The researchers found that during a median follow-up of 13.5 years, 110 individuals developed . HDL-C, apoCIII, apoE, apoCIII-to-apoA1 ratio, apoE-to-apoA1 ratio, and apolipoproteinic score remained significant after adjustment for age, sex, , parental history of diabetes, hypertension, alcohol use, smoking, prevalent cardiovascular disease, and serum lipid-reducing agents (per one standard deviation naturally log-transformed hazard ratios, 0.74, 1.65, 1.36, 1.72, 1.28, and 1.6, respectively). After adjustment for triglycerides in the last model, only apoCIII and apoCIII-to-apoA1 ratio remained significant (hazard ratios, 1.42 and 1.56, respectively).

"Serum apoCIII levels as well as apoCIII-to-apoA1 ratio are associated with incident T2D," the authors write. "They are associated independent of known risk factors and stronger than HDL-C levels."

One author disclosed financial ties to the nutrition and lifestyle industries.

Explore further: Proinsulin-to-C-peptide ratio linked to progression to T1DM

More information: Full Text (subscription or payment may be required)

Related Stories

Proinsulin-to-C-peptide ratio linked to progression to T1DM

July 19, 2016
(HealthDay)—Elevation in the serum proinsulin-to-C-peptide (PI:C) ratio is associated with progression to type 1 diabetes, according to a study published online July 6 in Diabetes Care.

Fenofibrate may reduce CVD in patients with DM, dyslipidemia

January 4, 2017
(HealthDay)—Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia, according to a study published online Dec. 28 in JAMA Cardiology.

SHBG, total estradiol linked to type 2 diabetes in women

October 18, 2016
(HealthDay)—For women, sex hormone-binding globulin (SHBG) and total estradiol (TE) are associated with the risk of type 2 diabetes (T2D), according to research published online Oct. 10 in Diabetes.

Ferritin, transferrin positively linked to type 2 diabetes

February 18, 2016
(HealthDay)—Higher levels of ferritin and transferrin correlate with increased risk of type 2 diabetes (T2D) among men and women, according to a study published online Feb. 9 in Diabetes Care.

Diabetes ups risk of amputation in critical limb ischemia

September 20, 2016
(HealthDay)—For patients with critical limb ischemia (CLI), those with diabetes mellitus (DM) are at increased risk of major amputation, according to a study published online Sept. 9 in Diabetes Care.

Quality of diet linked to risk of T2DM regardless of BMI change

September 21, 2016
(HealthDay)—Changes in diet quality correlate with subsequent risk of type 2 diabetes, and the association between diet quality changes and diabetes risk is only partly explained by body weight changes, according to a study ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.